Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Pharmaceutical Group Xinzheng is a prominent Chinese pharmaceutical manufacturer and a key subsidiary of the Tianjin Pharmaceutical Group. Based in Xinzheng, Henan Province, the company specializes in the production of a wide range of essential medicines, including antibiotics, cardiovascular drugs, and gastrointestinal treatments. Its product portfolio features well-known generic formulations such as amoxicillin, ciprofloxacin, and ranitidine, available in various dosage forms like tablets, capsules, and injections. The company operates large-scale, GMP-certified manufacturing facilities that supply both the domestic Chinese market and international regions. As part of a major state-owned enterprise, it plays a significant role in the regional pharmaceutical supply chain and healthcare infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Pharmaceutical Group Xinzheng.